ACW · ASX

Actinogen Medical Limited (ASX:ACW)

AU$0.026

 0.0 (0.0%)
ASX:Live
15/10/2024 03:08:05 PM
HALO Ords HALO Momentum HALO Earnings Momentum GROWTH AUS Fakey Shakey - Long +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ACW Overview

ACW Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About ACW

Website

Actinogen Medical Limited

Telephone

61.2.8964.7401

Address

Level 9 Suite 901 109 Pitt Street Sydney, New South Wales (NSW) 2000

Description

N/A

ACW Price Chart

Key Stats

Market Cap

AU$79.52M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.1

Trade Value (12mth)

AU$68,966.00

1 week

0%

1 month

-25.71%

YTD

25.53%

1 year

31.8%

All time high

0.84

Key Fundamentals

EPS 3 yr Growth

130.80%

EBITDA Margin

N/A

Operating Cashflow

-$17m

Free Cash Flow Return

-101.60%

ROIC

-78.20%

Interest Coverage

-937.40

Quick Ratio

13.90

Other Data

Shares on Issue (Fully Dilluted)

2683m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ACW Announcements

Latest Announcements

Date Announcements

11 October 24

ACW Dementia Trials Australia presentation

×

ACW Dementia Trials Australia presentation

11 October 24

Letter to Shareholders, Notice of AGM & Proxy Form

×

Letter to Shareholders, Notice of AGM & Proxy Form

11 October 24

Annual Report to Shareholders

×

Annual Report to Shareholders

10 October 24

$3.0 million share purchase plan closes 1.3x oversubscribed

×

$3.0 million share purchase plan closes 1.3x oversubscribed

04 October 24

Letter to Shareholders & Notice of General Meeting

×

Letter to Shareholders & Notice of General Meeting

26 September 24

Change in substantial holding

×

Change in substantial holding

25 September 24

Date of AGM and Closing Date for Director Nominations

×

Date of AGM and Closing Date for Director Nominations

24 September 24

Application for quotation of securities - ACW

×

Application for quotation of securities - ACW

24 September 24

Cleansing Notice

×

Cleansing Notice

24 September 24

Update - Application for quotation of securities - ACW

×

Update - Application for quotation of securities - ACW

24 September 24

Letter to Eligible Shareholders

×

Letter to Eligible Shareholders

24 September 24

Letter to Ineligible Shareholders

×

Letter to Ineligible Shareholders

24 September 24

Application for quotation of securities - ACW

×

Application for quotation of securities - ACW

24 September 24

Listed Options Distribution Schedule

×

Listed Options Distribution Schedule

24 September 24

Listed Options Top 20 Holders

×

Listed Options Top 20 Holders

20 September 24

Share Purchase Plan & Options Prospectus

×

Share Purchase Plan & Options Prospectus

19 September 24

Actinogen CEO presents at Pitt Street Research Conference

×

Actinogen CEO presents at Pitt Street Research Conference

18 September 24

ACW $11.1m capital raising to accelerate Alzheimers trial

×

ACW $11.1m capital raising to accelerate Alzheimers trial

18 September 24

Proposed issue of securities - ACW

×

Proposed issue of securities - ACW

18 September 24

Proposed issue of securities - ACW

×

Proposed issue of securities - ACW

18 September 24

Proposed issue of securities - ACW

×

Proposed issue of securities - ACW

16 September 24

Pause in Trading

×

Pause in Trading

16 September 24

Trading Halt

×

Trading Halt

11 September 24

Application for quotation of securities - ACW

×

Application for quotation of securities - ACW

05 September 24

Application for quotation of securities - ACW

×

Application for quotation of securities - ACW

ACW Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -100.0 -9.6 -5.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -123.3 -11.6 8.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -11.1 -12.1 -12.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.9 -42.8 14.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,812 1,902 2,174 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,812 1,902 2,174 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 13 15 23 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.6 -1.2 -2.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -13 -15 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -131.5 -21.1 -47.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -13 -16 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -123.1 -20.5 -46.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -13 -16 -23 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -5 -10 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -9 -11 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -142.6 -13.2 -21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -10 -9 -17 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 12 1 18 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -9 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock -450.3 8.2 -94.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 16 8 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 23 15 21 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -16 -8 -9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 22 13 20 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 22 13 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.9 -38.6 48.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -40.8 -70.7 -61.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -43.7 -80.2 -66.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -66.5 -89.7 -138.4 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -48.1 -61.0 -78.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -48.2 -49.4 -101.6 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -691.2 -931.8 -937.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 0.5 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -74.5 -62.5 -46.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 13.8 7.0 13.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 13.8 7.0 13.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 80.2 66.7 50.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -643.2 -482.8 -1,249.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -40.8 -70.7 -61.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -43.7 -80.2 -66.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -43.7 -80.2 -66.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 588.0 899.9 743.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -588.0 -899.9 -743.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ACW Shortsell

Frequently Asked Questions

The current share price of Actinogen Medical Limited (ACW:ASX) is AU$0.026.
The 52-week high share price for Actinogen Medical Limited (ACW:ASX) is AU$0.10.
The 52-week low share price for Actinogen Medical Limited (ACW:ASX)? is AU$0.01.
Actinogen Medical Limited (ACW:ASX) does not pay a dividend.
Actinogen Medical Limited (ACW:ASX) does not pay a dividend.
Actinogen Medical Limited (ACW:ASX) has a franking level of 0.0%.
Actinogen Medical Limited (ACW:ASX) is classified in the Healthcare.
The current P/E ratio for Actinogen Medical Limited (ACW:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.